FDA Approved: BIDIL — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BIDIL (hydralazine hydrochloride and isosorbide dinitrate) submitted by Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BIDIL (Hydralazine hydrochloride and isosorbide dinitrate)

Snippet

SUPPL AP for BIDIL (HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE)